A Continuation Study of TAK-279 in Adults With Ulcerative Colitis (UC) and Crohn's Disease (CD)
NCT06764615
·
clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
183
Enrollment
INDUSTRY
Sponsor class
Conditions
Crohn's Disease
Ulcerative Colitis
Interventions
DRUG:
Zasocitinib
Sponsor
Takeda